Carlisle Companies Inc (CSL)
393.95
-3.41%
Carlisle Companies Inc (CSL) is currently trading at $393.95. This represents a loss of 3.41% from the previous session. With a market capitalization of $16.05B, CSL is a key component of the Industrials sector. Investors looking to trade CSL should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade CSL commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Carlisle Companies Inc (CSL) shows a bearish trend. Analysts are watching the 412.05 level closely.
Fundamentals
Mkt Cap16.05B
P/E Ratio0.0000
Volume150,386
60-Day Technical Chart
Advanced Charting
Need more indicators for CSL? Use the world's #1 platform.
Open CSL on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $394
| Metric |
CSL -3.41% |
TSLA +1.18% |
MSFT +2.13% |
MU +2.42% |
|---|---|---|---|---|
| Price | $393.95 | $413.89 | $397.28 | $428.14 |
| Mkt Cap | $16.05B | $1,298.32B | $2,951.39B | $482.55B |
| - | View → | View → | View → |
Latest Headlines
CSL share price slips again as buyback rolls on, March dividend date looms
TechStock² • Feb 24, 2026
Shares of Australian biotech major CSL plunge to 8-year low after CEO departure, weak earnings
CNBC • Feb 10, 2026
CSL Shares Tumble to Eight-Year Low After First-Half Profit Miss
Bloomberg.com • Feb 10, 2026
This fundie’s top stock picks have one thing in common
AFR • Feb 22, 2026
Breakingviews - Biotech CSL fails at administering own medicine
Reuters • Feb 10, 2026
● Gemini Agentic AI Analyst Insight for CSL
Market Education
- October Market Volatility: Why Investors Fear the “Danger Month” Sep 26, 2025
- What Wolves Can Teach Us About Winning in the Markets Sep 8, 2025
- Fed talking about Phillips Curve - I want to know what it is and how it impacts the interest rate Jul 18, 2023
External Research